2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow KAI 9803: new trials by email Literature Review of KAI 9803 trials Research Report on KAI 9803
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack] KAI-9803 - Myocardial Infarction, Cardiovascular Diseases | Phase 2 | Completed | KAI Pharmaceuticals | 1180 | 2008-11-01 | 2011-09-02 |
| Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack KAI-9803 for Injection, Placebo - Myocardial Infarction | Phase 1 / Phase 2 | Completed | KAI Pharmaceuticals | 154 | 2004-09-01 | 2011-09-02 |
Myocardial Infarction (2) · Cardiovascular Diseases (1) · Heart Diseases (1) · Infarction (1) · Myocardial Ischemia (1) · Pathologic Processes (1)
United States (2) · Australia (1) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · Finland (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Netherlands (1) · New Zealand (1) · Norway (1) · Poland (1)
A.Michael Lincoff, MD (1) · Gregory Bell, MD (1)